...抑制剂;靶向肿瘤治疗;耐药性 [gap=1227]Key words: MAPK pathway; B-RAF V600E mutation; inhibitor; targeted tumor therapy; drug resistance ...
基于1个网页-相关网页
Tumor necrosis targeted therapy 瘤坏死靶向治疗 ; 肿瘤坏死靶向治疗
Tumor Targeted Ablate Therapy 治疗
Tumor targeted therapy 肿瘤导向治疗
targeted therapy against tumor 靶向治疗药物
tumor vascular-targeted therapy 肿瘤血管靶向治疗
Objective To select the best magnetic iron-carbon composite microparticles as a drug carrier in magnetically targeted therapy of tumor.
目的选择一种最佳铁碳复合磁性材料作为药物载体,用于肿瘤的磁靶向治疗。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发,可预测非小细胞肺癌分子靶向治疗的疗效和预后,针对RAS基因的分子抑制剂研究仍处于初级阶段。
AIM: To explore targeted gene therapy of tumor by using the combination of TRAIL gene with the telomerase promoter.
目的:研究TRAIL基因结合端粒酶启动子特异性靶向治疗的作用。
应用推荐